US Stock MarketDetailed Quotes

BDTX Black Diamond Therapeutics

Watchlist
  • 2.045
  • +0.015+0.74%
Trading Feb 26 10:51 ET
115.72MMarket Cap-1.54P/E (TTM)

About Black Diamond Therapeutics Company

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Company Profile

SymbolBDTX
Company NameBlack Diamond Therapeutics
Listing DateJan 30, 2020
Issue Price19.00
Founded2014
CEODr. Mark A. Velleca, M.D.
MarketNASDAQ
Employees54
Fiscal Year Ends12-31
AddressOne Main Street,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-252-0848

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mark A. Velleca, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 2.95M
  • Elizabeth L. Montgomery
  • Chief People Officer
  • --
  • Elizabeth Buck, PhD
  • Chief Scientific Officer
  • --
  • Melanie Morrison
  • Chief Development Officer
  • --
  • Sergey Yurasov, M.D.,Pd.D
  • Chief Medical Officer
  • 1.23M
  • Brent Hatzis-Schoch, Esq.
  • Chief Operating Officer and General Counsel
  • --
  • Erika Jones
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Kapil Dhingra, M.B.B.S.
  • Independent Director
  • 109.35K
  • Dr. Garry E. Menzel, PhD
  • Independent Director
  • 75.35K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 68.14K
  • Dr. Prakash Raman, PhD
  • Independent Director
  • --
  • Dr. Samarth Kulkarni, PhD
  • Lead Independent Director
  • 59.35K
  • Shannon Campbell, PhD
  • Independent Director
  • --

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.